- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02419599
High vs Standard Energy Children's Drink Study
October 30, 2017 updated by: Nutricia UK Ltd
The Effect of Standard Versus High Energy Density, Low Volume Oral Nutritional Supplements in Children Requiring Nutritional Support - a Pilot Trial
This study is a pilot trial investigating the effects of a high energy drink for children, in comparison to standard energy drink for children.
Study Overview
Detailed Description
A four week, multi-centre, randomised controlled trial investigating the effects of a high energy density, low volume oral nutritional supplement versus standard energy density oral nutritional supplements in children aged 1-12yrs old requiring nutritional support.
Fifty eligible children will be recruited and randomised to receive either the high energy density oral nutritional supplement or the standard energy density oral nutritional supplement for four weeks.
The primary outcome is nutrient intake, with secondary outcomes of compliance, tolerance, acceptability, anthropometry and safety.
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female
- Aged 1-12yrs
- Faltering growth and/or requiring oral nutritional supplements to meet nutritional requirements
- Expected to receive at least one bottle of the study product per day
- Able to take study products orally during the study period
- Written informed consent from parent/carer
Exclusion Criteria:
- Requirement for 100% of their nutrition via enteral tube and/or parenteral feeding.
- Children with major hepatic or renal dysfunction
- Children with galactosaemia or severe lactose intolerance
- Requirement for elemental or semi-elemental feeds
- Investigator concern around willingness/ability of child/parent/carer to comply with protocol requirements
- Participation in other studies within 2 weeks of study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
The group who will receive high energy density, low volume oral nutritional supplement, to be taken for 4 weeks (28 days)
|
High energy density, low volume oral nutritional supplement (HE ONS) in addition to appropriate nutritional management
|
|
Active Comparator: Group B
The group who will receive the standard energy density oral nutritional supplement, to be taken for 4 weeks (28 days)
|
Standard energy density oral nutritional supplement (SE ONS) in addition to appropriate nutritional management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutrient intake
Time Frame: 4 weeks (28 days)
|
Dietary intake, including the intake of all foods and fluids, will be recorded and analysed throughout the study.
|
4 weeks (28 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance: Compliance with oral nutritional supplements in Group A and Group B; how much of the oral nutritional supplement is taken in comparison to the amount advised by the Dietitian.
Time Frame: 4 weeks (28 days)
|
4 weeks (28 days)
|
|
|
Tolerance: How well the child tolerates the oral nutritional supplements (including changes to gastrointestinal symptoms)
Time Frame: 4 weeks (28 days)
|
4 weeks (28 days)
|
|
|
Acceptability: How acceptable the oral nutritional supplement is to the child and their parent/carer, including taste, texture, ease of use, etc.
Time Frame: 4 weeks (28 days)
|
4 weeks (28 days)
|
|
|
Anthropometry
Time Frame: 4 weeks (28 days)
|
Changes to weight, height and head circumference in children less than 2yrs of age.
|
4 weeks (28 days)
|
|
Safety assessed by adverse events, to be recorded throughout study.
Time Frame: 4 weeks (28 days)
|
4 weeks (28 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
April 14, 2015
First Submitted That Met QC Criteria
April 16, 2015
First Posted (Estimate)
April 17, 2015
Study Record Updates
Last Update Posted (Actual)
November 1, 2017
Last Update Submitted That Met QC Criteria
October 30, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FC125
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth Failure
-
Northwell HealthRecruitingGrowth | Growth Disorders | Growth Failure | Growth Hormone TreatmentUnited States
-
Tufts UniversityHelen Keller International; Purdue University; Patan Academy of Health Sciences; Government of Nepal and other collaboratorsCompletedBirth Weight | Stunting | Birth Length | Linear Growth Failure | Height for Age
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
EMD SeronoCompletedGrowth Hormone Deficiency | Growth FailureGermany
-
Danone Specialized Nutrition IndonesiaLMU Klinikum; Hasanuddin University; RIKENActive, not recruitingGrowth FailureIndonesia
-
University of Texas Southwestern Medical CenterActive, not recruitingGrowth Disorders | Growth Failure | PrematurityUnited States
-
Soroka University Medical CenterWithdrawn
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedPostnatal Growth Failure of Preterm Infants | Human Milk Fortification
-
Danone Specialized Nutrition (M) Sdn BhdUniversiti Putra MalaysiaRecruiting
-
University of GlasgowTerminatedGrowth Failure | Stoma Ileostomy | Stoma Colostomy | Electrolyte DepletionUnited Kingdom
Clinical Trials on HE ONS
-
Danone Specialized NutritionCompleted
-
International Medical UniversityKotra Pharma (M) Sdn BhdCompletedCancer of Breast | Cancer ColonMalaysia
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Wageningen UniversityVitalnextUnknownMalnutrition | Muscle HealthNetherlands
-
Abbott NutritionAdvocate Health CareTerminatedQuality Improvement Program (QIP) to Reduce 30-Day Readmission in Malnourished Hospitalized PatientsMalnutritionUnited States
-
Nutricia UK LtdCompletedMalnutritionUnited Kingdom
-
IRCCS San RaffaeleNot yet recruiting
-
Shanghai University of Traditional Chinese MedicineFudan UniversityRecruiting
-
Jinling Hospital, ChinaShandong Provincial Hospital; Hebei Medical University Fourth Hospital; Zhongda... and other collaboratorsRecruiting